Abstract
Objectives
To conduct a systematic review and meta-analysis of prevalence of cardiovascular-related morbidity and mortality in patients with diabetic foot ulcers (DFU), as well as compare risks of cardiovascular-related morbidity and mortality between diabetic patients with and without DFU.
Methods
A systematic search was conducted on Medline, Embase, and Cochrane databases for randomized controlled trials and observational studies which explored the association between DFU and cardiovascular-related morbidity & mortality, or compared differences in hazard ratios of cardiovascular diseases between diabetics with and without DFU. Frequentist, pairwise meta-analysis was performed on studies with two comparator arms, whereas single-arm studies reporting pooled incidences of cardiovascular-related mortality and morbidity were calculated based on exact binomial distributions. A random-effect meta-analysis model was used with heterogenicity of studies assessed using I2, τ2, and χ2 statistics.
Results
10 studies were identified and included in the systematic review & meta-analysis of 8602 patients. DFU was consistently found to have significant association with cardiovascular-related morbidity and mortality, with pooled prevalences of all cause cardiovascular-related morbidity (37.1%), IHD (44.7%), CHF (25.1%), CAD (11.7%), and CVA (10.9%), and all cause cardiovascular-related mortality (14.6%), fatal IHD (6.2%), fatal CHF (3.67%), fatal CAD (7.92%), and fatal CVA (1.99%). Diabetic patients with DFU were found to have significantly increased risk of IHD (RR 1.25), CVA (RR 2.03), and all-cause cardiovascular-related mortality (RR 2.59) compared to those without DFU.
Conclusions
The presence of DFU is associated with major adverse cardiac events. The alarming rates of cardiovascular-related morbidity and mortality in DFU patients highlight its potential role as a marker of cardiovascular complications and should prompt early clinical investigation and management.
Highlights
-
There is a paucity of literature exploring risks of cardiovascular-related morbidity and mortality in patients with diabetic foot ulcers (DFU).
-
This systematic review and meta-analysis of proportions and risk ratios show that DFU is significantly associated with cardiovascular-related morbidity and mortality, and diabetic patients with DFU are significantly more likely to suffer from IHD, CVA, and all-cause cardiovascular-related mortality compared to those without DFU.
-
Our findings highlight the urgent need for assessment and prompt treatment of cardiovascular-related comorbidities in patients with DFU, so to limit its disease progression and reduce the risk of cardiac morbidity and mortality.
Similar content being viewed by others
References
M.W. Sohn, R.M. Stuck, M. Pinzur, T.A. Lee, E. Budiman-Mak, Lower-extremity amputation risk after charcot arthropathy and diabetic foot ulcer. Diabetes Care 33(1), 98–100 (2010). https://doi.org/10.2337/dc09-1497
K.W. Tan, B.S.L. Dickens, A.R. Cook, Projected burden of type 2 diabetes mellitus-related complications in Singapore until 2050: a Bayesian evidence synthesis. BMJ Open Diabetes Res Care 8(1), (2020). https://doi.org/10.1136/bmjdrc-2019-000928
J.H. Tan, C.C. Hong, L. Shen, E.Y. Tay, J.K. Lee, A. Nather, Costs of Patients Admitted for Diabetic Foot Problems. Ann. Acad. Med. Singap. 44(12), 567–570 (2015)
A. Pinto, A. Tuttolomondo, D. Di Raimondo et al. Cardiovascular risk profile and morbidity in subjects affected by type 2 diabetes mellitus with and without diabetic foot. Metabolism 57(5), 676–682 (2008). https://doi.org/10.1016/j.metabol.2008.01.004
A. Tuttolomondo, C. Maida, A. Pinto, Diabetic Foot Syndrome as a Possible Cardiovascular Marker in Diabetic Patients. J. Diabetes Res. 2015, 268390 (2015). https://doi.org/10.1155/2015/268390
M.J. Young, J.E. McCardle, L.E. Randall, J.I. Barclay, Improved survival of diabetic foot ulcer patients 1995–2008: possible impact of aggressive cardiovascular risk management. Diabetes Care 31(11), 2143–2147 (2008). https://doi.org/10.2337/dc08-1242
J.R. Brownrigg, M. Griffin, C.O. Hughes et al. Influence of foot ulceration on cause-specific mortality in patients with diabetes mellitus. J. Vasc. Surg. 60(4), 982–986.e983 (2014). https://doi.org/10.1016/j.jvs.2014.04.052
J.A. Rubio, S. Jiménez, J.L. Lázaro-Martínez, Mortality in Patients with Diabetic Foot Ulcers: Causes, Risk Factors, and Their Association with Evolution and Severity of Ulcer. J. Clin. Med. 9(9) (2020). https://doi.org/10.3390/jcm9093009
H. Forde, S. Wrigley, L.T. O’Murchadha et al. Five-year outcomes of patients attending a diabetic foot clinic in a tertiary referral centre. Ir. J. Med. Sci. 189(2), 511–515 (2020). https://doi.org/10.1007/s11845-019-02108-2
O.O. Adeleye, E.T. Ugwu, I.D. Gezawa, I. Okpe, I. Ezeani, M. Enamino, Predictors of intra-hospital mortality in patients with diabetic foot ulcers in Nigeria: data from the MEDFUN study. BMC Endocr. Disord. 20(1), 134 (2020). https://doi.org/10.1186/s12902-020-00614-4
K. Jeyaraman, T. Berhane, M. Hamilton, A.P. Chandra, H. Falhammar, Mortality in patients with diabetic foot ulcer: a retrospective study of 513 cases from a single Centre in the Northern Territory of Australia. BMC Endocr. Disord. 19(1), 1 (2019). https://doi.org/10.1186/s12902-018-0327-2
D.C. Jupiter, J.C. Thorud, C.J. Buckley, N. Shibuya, The impact of foot ulceration and amputation on mortality in diabetic patients. I: From ulceration to death, a systematic review. Int. Wound J. 13(5), 892–903 (2016). https://doi.org/10.1111/iwj.12404
J.R. Brownrigg, J. Davey, P.J. Holt et al. The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis. Diabetologia 55(11), 2906–2912 (2012). https://doi.org/10.1007/s00125-012-2673-3
L. Chen, S. Sun, Y. Gao, X. Ran, Global mortality of diabetic foot ulcer: A systematic review and meta-analysis of observational studies. Diabetes Obes. Metab. 25(1), 36–45 (2023). https://doi.org/10.1111/dom.14840
M.J. Page, J.E. McKenzie, P.M. Bossuyt et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021). https://doi.org/10.1136/bmj.n71
M.M. Iversen, G.S. Tell, T. Riise et al. History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway. Diabetes Care 32(12), 2193–2199 (2009). https://doi.org/10.2337/dc09-0651
J.A. Rubio, S. Jiménez, J. Álvarez, Clinical characteristics and mortality in patients treated in a Multidisciplinary Diabetic Foot Unit. Endocrino.l Diabetes Nutr. 64(5), 241–249 (2017). https://doi.org/10.1016/j.endinu.2017.02.012
S. Junrungsee, N. Kosachunhanun, A. Wongthanee, K. Rerkasem, History of foot ulcers increases mortality among patients with diabetes in Northern Thailand. Diabet Med. 28(5), 608–611 (2011). https://doi.org/10.1111/j.1464-5491.2011.03262.x
M.W. Sohn, T.A. Lee, R.M. Stuck, R.G. Frykberg, E. Budiman-Mak, Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care 32(5), 816–821 (2009). https://doi.org/10.2337/dc08-1695
S. Saluja, S.G. Anderson, I. Hambleton et al. Foot ulceration and its association with mortality in diabetes mellitus: a meta-analysis. Diabet Med. 37(2), 211–218 (2020). https://doi.org/10.1111/dme.14151
L. Qiu, Y. Li, C. Yang et al. Influence of Foot Ulceration on All-Cause and Cardiovascular Mortality in Diabetic Patients: A Case-Control Study. J. Wound Ostomy Continence Nurs. 49(2), 175–179 (2022). https://doi.org/10.1097/won.0000000000000856
N.K. Chammas, R.L. Hill, M.E. Edmonds, Increased Mortality in Diabetic Foot Ulcer Patients: The Significance of Ulcer Type. J. Diabetes Res. 2016, 2879809 (2016). https://doi.org/10.1155/2016/2879809
E. Everett, N. Mathioudakis, Update on management of diabetic foot ulcers. Ann. N. Y. Acad. Sci. 1411(1), 153–165 (2018). https://doi.org/10.1111/nyas.13569
N. Pechlivani, R.A. Ajjan, Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets. Front. Cardiovasc. Med. 5, 1 (2018). https://doi.org/10.3389/fcvm.2018.00001
A. Berbudi, N. Rahmadika, A.I. Tjahjadi, R. Ruslami, Type 2 Diabetes and its Impact on the Immune System. Curr. Diabetes Rev. 16(5), 442–449 (2020). https://doi.org/10.2174/1573399815666191024085838
B. Stancu, T. Ilyés, M. Farcas, H.F. Coman, B.A. Chiș, O.A. Andercou, Diabetic Foot Complications: A Retrospective Cohort Study. Int. J. Environ. Res. Public Health 20(1) (2022). https://doi.org/10.3390/ijerph20010187
J. Wang, K. Chen, X. Li et al. Postoperative adverse events in patients with diabetes undergoing orthopedic and general surgery. Medicine 98(14), e15089 (2019). https://doi.org/10.1097/md.0000000000015089
S. Sudhakaran, S.R. Surani, Guidelines for Perioperative Management of the Diabetic Patient. Surg. Res. Pract. 2015, 284063 (2015). https://doi.org/10.1155/2015/284063
M. Zubair, A. Malik, J. Ahmad, Plasma adiponectin, IL-6, hsCRP, and TNF-α levels in subject with diabetic foot and their correlation with clinical variables in a North Indian tertiary care hospital. Indian J. Endocrinol. Metab. 16(5), 769–776 (2012). https://doi.org/10.4103/2230-8210.100672
V. Chuter, F. Quigley, P. Tosenovsky et al. Australian guideline on diagnosis and management of peripheral artery disease: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease. J. Foot Ankle Res. 15(1), 51 (2022). https://doi.org/10.1186/s13047-022-00550-7
S. Morbach, H. Furchert, U. Gröblinghoff et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care 35(10), 2021–2027 (2012). https://doi.org/10.2337/dc12-0200
L. Prompers, M. Huijberts, J. Apelqvist et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 50(1), 18–25 (2007). https://doi.org/10.1007/s00125-006-0491-1
C. Gazzaruso, A. Coppola, C. Falcone et al. Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index. Diabetes Care 36(6), 1720–1725 (2013). https://doi.org/10.2337/dc12-1401
B. Neal, V. Perkovic, D.R. Matthews, Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N. Engl. J. Med. 377(21), 2099 (2017). https://doi.org/10.1056/NEJMc1712572
S. Zerovnik, M. Kos, I. Locatelli, Cardiovascular morbidity and mortality in patients with type 2 diabetes using novel antidiabetic medicines as add-on therapy: an observational real-world study. BMJ Open 11(9), e051549 (2021). https://doi.org/10.1136/bmjopen-2021-051549
R.M. See, Y.N. Teo, Y.H. Teo et al. Effects of Sodium-Glucose Cotransporter 2 on Amputation Events: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials. Pharmacology 107(3-4), 123–130 (2022). https://doi.org/10.1159/000520903
D. Mozaffarian, Global Scourge of Cardiovascular Disease: Time for Health Care Systems Reform and Precision Population Health. J. Am. Coll. Cardiol. 70(1), 26–28 (2017). https://doi.org/10.1016/j.jacc.2017.05.007
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chin, B.Z., Lee, P., Sia, CH. et al. Diabetic foot ulcer is associated with cardiovascular-related mortality and morbidity – a systematic review and meta-analysis of 8062 patients. Endocrine (2024). https://doi.org/10.1007/s12020-024-03696-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12020-024-03696-5